Hyderabad, India -- (SBWire) -- 02/23/2018 --Intraosseous infusion devices market to witness major growth with the increasing road accidents
A significant number of cases of disease and trauma require rapid vascular access in order to supply medicine and fluids into the bloodstream. This becomes more crucial in cases of accidents and war injuries where rapid vascular access becomes essential even in a non-hospital environment. Some of the many medical conditions that require rapid vascular access are heart failure, cardiovascular arrhythmias, myocardial areas of localized necrosis, syncope, hypotension, anaphylactic stun, diabetes and various other ordinarily happening medicinal conditions. Intraosseous infusion devices are used to feed the medicine into the bone marrow to access the bloodstream if intravenous access is not possible.
View sample and decide: https://www.marketdataforecast.com/market-reports/intraosseous-infusion-devices-market-5348/request-sample
The global multiplex assay market is estimated to have a value of USD 3.8 billion in 2017. With a CAGR of 7.2%, the market size is expected to grow rapidly to cross USD 5.38 billion by 2022. By application, the hospitals market is the largest contributor to the global market. By product type, FAST1 device leads the international market. By route of administration, Head of Humerus accounts for the major share of the global Intraosseous infusion market.
To know more read: https://www.marketdataforecast.com/market-reports/intraosseous-infusion-devices-market-5348/
Increasing demand for therapeutic gadgets, growing cases of chronic diseases, rising demand for intraosseous infusion devices in emergency and military health care services are likely to boost the market growth. Increasing number of cases of obesity and growing number of road accidents are also expected to drive the market growth.
The key challenges of the market are concerns regarding the side effects of usage, lack of results in cases of people with osteoporosis and hypovolemic conditions, and the advent of competent devices.
Get your customized report: https://www.marketdataforecast.com/market-reports/intraosseous-infusion-devices-market-5348/customize-report
North America occupies the majority of the market share owing to the presence of major key players and major investments in health care. However, Asia-pacific is expected to grow at a high rate during the forecast period owing to the increasing population and the rising economies of the developing nations.
Major players of the intraosseous infusion market are PerSys Medical, Aero Healthcare, Teleflex, Pyng Medical Corp., Biopsybell, Cook Medical Incorporated, Aero Healthcare etc.
About MarketDataForecast™
Market Data Forecast is a market research firm offering syndicated research, consults and industry newsletters across various domains & verticals. With a well-established in-house team of experts from diverse fields and outsource research network across 100+ countries, we are the sole research providers for the majority of Fortune 500 companies. Along with the standards of reports being on par excellence, our unique services like free customization, analyst support for the period of six months post to the purchase will be the flag bearers and differentiates us from the rest. Our experience and in-depth understanding of various business environments will be a support to you and your organization in making well-informed decisions.
Related reports:
Tumor Ablation Market – https://www.marketdataforecast.com/market-reports/global-tumor-ablation-market-472/
Glucose Monitoring Device Market - https://www.marketdataforecast.com/market-reports/global-glucose-monitoring-device-market-619/
Contact Info:
Name: Mr Abhishek Shukla
Email: abhishek@marketdataforecast.com
Organization: MarketDataForecast™
Address: 2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
Phone: +1-888-702-9626
Intraosseous Infusion Devices Market to Witness Major Growth with the Increasing Road Accidents
Increasing demand for therapeutic gadgets and growing cases of chronic diseases are likely to boost the market growth.